Condition hubs
Each hub is a slice of recruiting ClinicalTrials.gov records with unique intro text, FAQs, and MedicalCondition markup. Start with a disease you already know, then open the NCT link.
Cancer
Breast cancer
Trials testing new drugs, antibody therapies, surgery timing, and radiation approaches.
Prostate cancer
Hormone therapy, PSMA-targeted drugs, and active-surveillance studies.
Lung cancer
Immunotherapy, targeted pills for EGFR/ALK, and early-detection studies.
Colorectal cancer
Immunotherapy, targeted drugs, and surgery-timing studies for colon and rectal cancer.
Pancreatic cancer
Chemotherapy combinations, KRAS-targeted drugs, and earlier-detection studies.
Melanoma
Checkpoint drugs, TIL therapy, and adjuvant studies after surgery.
Ovarian cancer
PARP inhibitors, antibody-drug conjugates, and maintenance after platinum therapy.
Glioblastoma
Surgery, radiation, temozolomide combinations, and experimental brain-tumor drugs.
Leukemia
Targeted pills, antibodies, CAR-T, and transplant-related studies for blood cancers.
Lymphoma
CAR-T, bispecific antibodies, and chemotherapy-sparing studies for Hodgkin and NHL.
Multiple myeloma
Bispecifics, CAR-T, and maintenance studies after transplant or relapsed disease.
Kidney cancer
Immunotherapy, VEGF drugs, and adjuvant studies after kidney surgery.
Bladder cancer
BCG, immunotherapy, antibody-drug conjugates, and bladder-sparing approaches.
Liver cancer
Immunotherapy, TACE combinations, and transplant-window studies for HCC.
Stomach cancer
HER2, Claudin 18.2, immunotherapy, and perioperative chemotherapy studies.
Cervical cancer
Immunotherapy, HPV-related studies, and treatments for recurrent disease.
Endometrial cancer
Immunotherapy, targeted drugs, and studies after surgery or at recurrence.
Head and neck cancer
HPV-related oropharynx studies, immunotherapy, and radiation combinations.
Brain and nerve
Alzheimer's disease
Amyloid and tau drugs, lifestyle trials, and studies for caregivers and prevention.
Parkinson's disease
Dopamine therapies, device implants, and trials aimed at slowing progression.
Multiple sclerosis
B-cell drugs, remyelination experiments, and progressive-MS trials.
Migraine
CGRP blockers, devices, and prevention vs. rescue studies.
ALS
Drug, gene, and device studies for amyotrophic lateral sclerosis.
Epilepsy
Add-on medicines, devices, and surgery-related studies for seizures.
Stroke
Recovery, prevention after a first stroke, and acute hospital studies.
Metabolic
Type 2 diabetes
GLP-1 and SGLT2 drugs, insulin combinations, and diet or device studies.
Obesity
Weight-loss medicines (including GLP-1s), surgery, and behavioral programs.
Fatty liver disease (MASH)
MASH/NASH drug trials, fibrosis imaging studies, and metabolic combinations.
Chronic kidney disease
SGLT2 drugs, anemia treatments, and dialysis-sparing studies.
PCOS
Metabolic, fertility, and symptom studies for polycystic ovary syndrome.
Mental health
Depression
Fast-acting medicines, psychedelics, TMS, and add-on treatments after an antidepressant.
PTSD
Therapy plus medicine studies, including some psychedelic-assisted protocols.
Bipolar disorder
Maintenance, depression, and mania studies with medicines or therapy.
Schizophrenia
Antipsychotic, negative-symptom, and cognition studies.
Anxiety disorders
GAD and related anxiety studies with medicines, therapy, or digital tools.
ADHD
Medicine, digital, and adult-ADHD studies from the public registry.
Immune and joints
Rheumatoid arthritis
Biologics, JAK inhibitors, and tapering studies for people already on treatment.
Lupus
B-cell and interferon-pathway drugs for SLE and lupus nephritis.
Psoriasis
Injectable biologics, oral TYK2 drugs, and combination skin studies.
Crohn's disease
Gut-targeted biologics, oral drugs, and diet studies.
Ulcerative colitis
Gut-targeted biologics, oral small molecules, and combination induction studies.
Osteoarthritis
Knee and hip pain studies, injections, devices, and exercise programs.
Eczema (atopic dermatitis)
Biologics, JAK inhibitors, and topical studies for eczema.
IBS
Diet, microbiome, and medicine studies for irritable bowel syndrome.
Women's health
Heart and lung
Heart failure
SGLT2 drugs, devices, and rehab programs for reduced or preserved ejection fraction.
Atrial fibrillation
Ablation, anticoagulants, and rhythm-control studies for AFib.
High blood pressure
Medicine, device, and lifestyle studies for high blood pressure.
Asthma
Biologics, inhaler combinations, and studies for severe or eosinophilic asthma.
COPD
Inhalers, biologics, and rehab studies for chronic obstructive pulmonary disease.
Sleep apnea
Devices, GLP-1 medicines, and surgery alternatives to CPAP.